Management of portal vein tumor thrombus

Hepatocellular Carcinoma

Volumn , Issue , 2008, Pages 739-760

  Lau, W Y ^a   Lai, Eric C H ^b   Yu, Simon C H ^c  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988624774     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812770059_0033     Document Type: Chapter

References (67)

1. Lau WY (2000). Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y (eds.), Surgery of the Liver and Biliary Tract, Vol. 2, WB Saunders, London, England, pp. 1423-50.
2. Lau WY (2002). Management of hepatocellular carcinoma. JR Coll Surg Edinb 47:389-99.
3. Lai EC, Lau WY (2005). The continuing challenge of hepatic cancer in Asia. Surgeon 3:210-5.
4. Minagawa M, Makuuchi M (2006). Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. WorldJ Gastroenterol 12:7561-7.
5. Llovet JM, Bustamante J, Castells A, et al. (1999). Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62-7.
6. Lin JP Lu DS (1996). Early enhancement of tumor thrombus in the portal vein on two-phase helical CT. J Comput Assist Tomogr 20:653-5.
7. Baron RL, Oliver 3rd JH, Dodd 3rd GD, et al. (1996). Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 199:505-11.
8. Tublin ME, Dodd 3rd GD, Baron RL (1997). Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 168:719-23.
9. Furuse J, Matsutani S, Yoshikawa M, et al. (1992). Diagnosis of portal vein tumor thrombus by pulsed Doppler ultrasonography. J Clin Ultrasound20:439-46.
10. Tanaka K, Numata K, Okazaki H, et al. (1993). Diagnosis ofportal vein thrombosis in patients with hepatocellular carcinoma: efficacy of color Doppler sonography compared with angiography. AJR Am J Roentgenol 160:1279-83.
11. Lencioni R, Caramella D, Sanguinetti F, et al. (1995). Portal vein thrombosis after percutaneous ethanol injection for hepatocellular carcinoma: value of color Doppler sonography in distinguishing chemical and tumor thrombi. AJR Am J Roentgenol 164:1125-30.
12. Dodd 3rd GD, Memel DS, Baron RL, et al. (1995). Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJRAm J Roentgenol165:573-7.
13. Vilana R, Bru C, Bruix J, et al. (1993). Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis. AJR Am J Roentgenol160:1285-7.
14. Yang L, Lin LW, Lin XY, et al. (2005). Ultrasound-guided fine needle aspiration biopsy in differential diagnosis of portal vein tumor thrombosis. Hepatobiliary Pancreat Dis Int 4:234-8.
15. Dodd 3rd GD, Carr BI (1993). Percutaneous biopsy of portal vein thrombus: a new staging technique for hepatocellular carcinoma. AJR Am J Roentgenol 161:229-33.
16. Dusenbery D, Dodd 3rd GD, Carr BI (1995). Percutaneous fine-needle aspiration ofportal vein thrombi as a staging technique for hepatocellular carcinoma. Cytologic findings of 46 patients. Cancer 75:2057-62.
17. Cedrone A, Rapaccini GL, Pompili M, et al. (1996). Portal vein thrombosis complicating hepatocellular carcinoma. Value ofultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver 16:94-8.
18. Chen XP, Qiu FZ, Wu ZD, et al. (2006). Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 13:940-6.
19. Konishi M, Ryu M, Kinoshita T, Inoue K (2001). Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 48:1421-4.
20. Wu CC, Hsieh SR, Chen JT, et al. (2000). An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. Arch Surg 135:1273-9.
21. Ikai I, Hatano E, Hasegawa S, et al. (2006). Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 202:431-8.
22. LeTreut YP, Hardwigsen J, Ananian P, et al. (2006). Resection ofhepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 10:855-62.
23. Pawlik TM, Poon RT, Abdalla EK, et al. (2005). Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137:403-10.
24. Ohkubo T, Yamamoto J, Sugawara Y, et al. (2000). Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 191:657-60.
25. Zhou J, Tang ZY, Wu ZQ, et al. (2006). Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. Hepatogastroenterology 53:275-80.
26. Sakata H, Konishi M, Ryu M, et al. (2004). Prognostic factors for hepatocellular carcinoma presenting with macroscopic portal vein tumor thrombus. Hepatogastroenterology 51:1575-80.
27. Hsieh CB, Yu CY, Tzao C, et al. (2006). Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection. Eur J Surg Oncol 32:72-6.
28. Adachi E, Maeda T, Kajiyama K, et al. (1996). Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of232 resected cases without preoperative treatments. Cancer 77:2022-31.
29. Li Q, Wang J, Sun Y, et al. (2006). Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis - a randomized study. World J Surg 30:2004-11.
30. Niguma T, Mimura T, Tutui N (2005). Adjuvant arterial infusion chemotherapy after resection ofhepatocellular carcinoma with portal thrombosis: a pilot study. J Hepatobiliary Pancreat Surg 12:249-53.
31. Fan J, Zhou J, Wu ZQ, et al. (2005). Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 11:1215-9.
32. Minagawa M, Makuuchi M, Takayama T, Ohtomo K (2001). Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 233:379-84.
33. Tanaka A, Morimoto T, Yamaoka Y (1996). Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein. Hepatogastroenterology 43:637-43.
34. Lau WY, Lai EC (2007). Salvage surgery following downstaging of unresectable hepatic malignancy - a strategy to increase resectability. Ann Surg Oncol (in press).
35. Lau WY, Leung TW, Yu SC, Ho SK (2003). Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 237:171-9.
36. Lau WY, Yu SC, Lai EC, Leung TW (2006). Transarterial chemoembolization for hepatocellular carcinoma. J Am Coll Surg 202:155-68.
37. Lau WY, Leung TW, Lai BS, et al. (2001). Preoperative systemic chemo-immunotherapy and sequential resection for unresectable hepatocellular carcinoma. Ann Surg 233:236-41.
38. Lau WY, Ho SK, Yu SC, et al. (2004). Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 240:299-305.
39. Lai YC, Shih CY, Jeng CM, et al. (2003). Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 9:2666-70.
40. Itamoto T, Nakahara H, Tashiro H, et al. (2002). Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein. J Surg Oncol 80:143-8.
41. Ando E, Tanaka M, Yamashita F, et al. (2002). Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 95:588-95.
42. Llovet JM, Bruix J (2003). Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-42.
43. Lo CM, Ngan H, Tso WK, et al. (2002). Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164-71.
44. Llovet JM, Real MI, Montana X, et al.; Barcelona Liver Cancer Group (2002). Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734-9.
45. Marelli L, Stigliano R, Triantos C, et al; (2007). Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30:6-25.
46. Georgiades CS, Hong K, D’Angelo M, Geschwind JF (2005). Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 16:1653-9.
47. Uraki J, Yamakado K, Nakatsuka A, Takeda K (2004). Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Eur J Radiol 51:12-8.
48. Lee HS, Kim JS, Choi IJ, et al. (1997). The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 79:2087-94.
49. Chung JW, Park JH, Han JK, et al. (1995). Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJRAm J Roentgenol 165:315-21.
50. Katsumori T, Fujita M, Takahashi T, et al. (1995). Effective segmental chemoem-bolization of advanced hepatocellular carcinoma with tumor thrombus in the portalvein. Cardiovasc Intervent Radiol 18:217-21.
51. Lau WY (2000). Radiotherapy with emphasis on radioembolization for liver tumors. In: Blumgart LH, Fong Y (eds.), Surgery of the Liver and Biliary Tract, Vol. II, WB Saunders, London, England, pp. 1545-64.
52. Dawson LA, Ten Haken RK (2005). Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15:279-83.
53. Lin CS, Jen YM, Chiu SY, et al. (2006). Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or threedimensional conformal radiotherapy. Jpn J Clin Oncol 36:212-7.
54. Hata M, Tokuuye K, Sugahara S, et al. (2005). Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 104:794-801.
55. Kim DY, Park W, Lim DH, et al. (2005). Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer103:2419-26.
56. Salem R, Lewandowski R, Roberts C, et al. (2004). Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15: 335-45.
57. 131I iodized oil for treatment ofhepatocellular carcinoma in patients with impeded portal venous flow. Radiology 212:665-8.
58. Raoul JL, Guyader D, Bretagne JF, et al. (1994). Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. JNuclMed 35:1782-7.
59. Obi S, Yoshida H, Toune R, et al. (2006). Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106:1990-7.
60. Ota H, Nagano H, Sakon M, et al. (2005). Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression. Br J Cancer 93:557-64.
61. Kaneko S, Urabe T, Kobayashi K (2002). Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis. Oncology 62(Suppl 1):69-73.
62. Sakon M, Nagano H, Dono K, et al. (2002). Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 94:435-42.
63. Chung YH, Song IH, Song BC, et al. (2000). Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 88:1986-91.
64. Jang JW, Bae SH, Choi JY, et al. (2007). A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management. Cancer Chemother Pharmacol 59:9-15.
65. Yamada K, Izaki K, Sugimoto K, et al. (2003). Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 57:113-9.
66. Ishikura S, Ogino T, Furuse J, et al. (2002). Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol 25:189-93.
67. Tazawa J, Maeda M, Sakai Y, et al. (2001). Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol 16:660-5.